Exploring Affordable, Convenient, and Lasting Weight Loss Solutions
According to the Centers for Disease Control and Prevention, weight problems have become a significant concern for nearly three-quarters of American adults. 42% are obese, and another 31% are overweight. A body mass index (BMI) over 25 is considered overweight, and over 30 is obese.
Amidst this alarming trend, a nationwide survey conducted in July found that nearly half of adults (45%) would be interested in taking a safe and effective prescription weight loss drug. The Kaiser Family Foundation poll included over 1300 adults surveyed online and by telephone. Researchers say the finding included nearly six in ten (59%) of those currently trying to lose weight and half (51%) of those trying to lose less than 10 pounds.
The new weight loss drugs dull people's appetites and food cravings. Ozempic, one of the new drugs, was initially developed to treat diabetes, but people taking it found they lost weight. Others include Wegovy, Mountjaro, Saxenda, and Victoza. Celebrities and social media influencers' weight loss success stories have raised considerable public interest and demand, leading to supply shortages. This has resulted in high out-of-pocket costs, with some individuals paying as much as $1300 per month or over $15,000 annually.
The KFF survey found that 80% of adults believe that insurers should cover the cost of weight loss medications for those diagnosed as overweight or obese. Half of the respondents were willing to support insurance coverage even if it meant an increase in monthly premiums. Conversely, only 16% expressed continued interest in prescription weight loss medications if their insurance did not cover them.
Health insurers and employers are weighing the cost of covering these medications against potential long-term savings from reduced expenses like diabetes treatments or joint replacements. Some employers have already made the difficult decision to discontinue coverage due to cost constraints.
One significant obstacle is that patients may need to remain on these medications for an extended period to prevent them from regaining weight. Participants in the KFF poll were less interested when they learned this was possible after going off the medication. Another factor that decreased interest among the poll participants is that the new weight loss medications come as injections and aren't currently available as pills.
The KFF poll highlights that many Americans are searching for safe and effective aids to help them lose weight. Affordability is crucial. Additionally, convenience plays a vital role, with a preference for oral medications over injections and a desire to avoid long-term drug dependence.
That's quite a tall order, but essential for addressing the growing obesity epidemic.